CEDOCLAV

This brand name is authorized in Nigeria.

Active ingredients

The drug CEDOCLAV contains a combination of these active pharmaceutical ingredients (APIs):

1	Cefpodoxime UNII 2TB00A1Z7N - CEFPODOXIME PROXETIL
	Like other beta-lactam drugs, cefpodoxime exerts antibacterial activity by binding to and inhibiting the action of certain bacterial cell wall synthetic enzymes, namely the penicillin binding proteins.
	Read more about Cefpodoxime
2	Clavulanic acid UNII Q42OMW3AT8 - CLAVULANATE POTASSIUM
	Clavulanic acid is a beta-lactam structurally related to penicillins. It inactivates some beta-lactamase enzymes thereby preventing inactivation of amoxicillin.
	Read more about Clavulanic acid

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-100759	Tablet	CEDOCLAV 625 TABLETS TAB 500 mg; 125 mg 1 X 10	7 NF-PP-362170 CEDOCLAV 625 TABLETS Cefpodoxime and Clavulanate Potassium 625 mg Cefpodoxime Proxetil USP Tabets equivalent to Cefpodoxime................... 500 mg Clavulanate Potassium USP Equivalent to Clavulanic Acid …………… 125 mg Excipients………………………………….q.s A4-100759 Drugs Imported Products 110 Prescription Only Medicine (POM) 9/14/2023 DE - STILL PHARMACY LTD , 1A, ATINUKE STREET, NULL NULL, ILASAMAJA ,LAGOS. ILASAMAJA LAGOS 7064946450 destillrejoice@gmail.com MAXMED LIFESCIENCES PVT LTD, PLOT NO 5 & 54, SECTOR IIDC , SIDCUL RUDRAPUR (UTTRAKHAND), India	28/02/2024

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01DD64		J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DD Third-generation cephalosporins
Discover more medicines within J01DD64

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-100759